|
CLMN expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62436730732907E-12 |
| Normal-vs-Stage2 |
<1E-12 |
| Normal-vs-Stage3 |
1.62447832963153E-12 |
| Normal-vs-Stage4 |
1.62436730732907E-12 |
| Stage1-vs-Stage2 |
3.445600E-02 |
| Stage1-vs-Stage3 |
1.863780E-01 |
| Stage1-vs-Stage4 |
3.2717000000293E-06 |
| Stage2-vs-Stage3 |
8.298000E-03 |
| Stage2-vs-Stage4 |
5.856999999998E-05 |
| Stage3-vs-Stage4 |
1.790300E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62436730732907E-12 |
| Normal-vs-AfricanAmerican |
<1E-12 |
| Normal-vs-Asian |
<1E-12 |
| Caucasian-vs-AfricanAmerican |
8.039800E-01 |
| Caucasian-vs-Asian |
3.753400E-01 |
| AfricanAmerican-vs-Asian |
7.441000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.62447832963153E-12 |
| Male-vs-Female |
4.441800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(81-100Yrs) |
1.037970E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.744200E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.673400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.942800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.784000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.184400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.252200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.41180000023944E-07 |
| Classical-VS-Follicular |
4.719000E-03 |
| Classical-VS-Other |
5.497600E-01 |
| Classical-VS-Normal |
1.62447832963153E-12 |
| Tall-VS-Follicular |
5.96210003589448E-09 |
| Tall-VS-Other |
2.360800E-01 |
| Tall-VS-Normal |
<1E-12 |
| Follicular-VS-Other |
9.326400E-01 |
| Follicular-VS-Normal |
1.62447832963153E-12 |
| Other-VS-Normal |
2.41489999999178E-05 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
<1E-12 |
| N0-vs-N1 |
6.14559999999598E-05 |
|
|
